Fillmore Capital Partners gets nursing home fraud suit dismissed … Fortune questions nursing home ownership, quality ties … HHS FY25 budget has $150B for Medicaid HCBS, cybersecurity … CMS delivers...
More news for Tuesday, Nov. 8
By
Kimberly Bonvissuto
Nov 08, 2022
Sabra Health Care REIT to move 24 North American Health Care properties to Ensign, Avamere … Welltower to move 147 ProMedica SNFs to Integra Health JV … Former owner permanently barred from operating...
CMS proposes expanding Medicare benefit for mobility devices, seeks feedback
By
Lois A. Bowers
Feb 16, 2023
Power seat elevation equipment on certain power wheelchairs would be covered for Medicare beneficiaries for the first time under a proposal put forth late Wednesday by the Centers for Medicare & Medicaid...
May we recommend the chicken, or perhaps the fish?
By
John O'Connor
Nov 09, 2023
Few things are causing more provider angst than the federal government’s newly hatched plan to implement minimum staffing requirements for nursing homes.
Feds target Medicare Advantage scam advertising
By
Kathleen Steele Gaivin
Dec 16, 2022
The Centers for Medicare & Medicaid Services is taking steps to protect consumers from scams or misleading ads for Medicare Advantage plans that target older adults. A proposed rule would ban ads that...
Business briefs, Aug. 31
By
Alicia Lasek
Aug 31, 2023
CMS vows to move forward with staffing proposal ‘soon’ despite ‘inconclusive’ research … House committee asks DOJ about COVID relief fraud … $2.4K American Parkinson Disease Association grant...
78 people charged for $2.5 billion in alleged healthcare fraud
By
Lois A. Bowers
Jun 29, 2023
A two-week nationwide law enforcement action has culminated in criminal charges against 78 defendants for their alleged participation in telemedicine, pharmaceutical and other healthcare fraud, as well...
Long-term care providers among 193 criminally charged, $2.75 billion in fraud recoveries so far in 2024
By
Kathleen Steele Gaivin
Jul 01, 2024
The Justice Department has recovered more than $2.75 billion in false claims against healthcare providers and charged 193 defendants so far this year in criminal cases through its 2024 National Health...
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Congress and agencies to tackle transparency in healthcare AI, despite mixed industry reactions
By
Aaron Dorman
Oct 06, 2023
Federal agencies and Congress are both taking further steps to regulate AI and curb issues that have already started to emerge.